Effects of [D-Ala2, D-Leu5]enkephalin and [D-Pen2, L-Pen5]enkephalin on apomorphine-induced motor activity in the mouse

[1]  T. Kameyama,et al.  DAGO ([d-Ala2,N-Me-Phe4,Gly-ol]enkephalin) specifically reverses apomorphine-induced increase in rearing and grooming behaviors in the mouse , 1991, Brain Research.

[2]  P. Portoghese,et al.  Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. , 1990, European journal of pharmacology.

[3]  B. Roques,et al.  Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slices. , 1989, European journal of pharmacology.

[4]  T. Kameyama,et al.  Dynorphin A(1–13) modulates apomorphine-induced behaviors using multidimensional behavioral analyses in the mouse , 1989, Brain Research.

[5]  T. Kameyama,et al.  Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (d-Ala2-d-Leu5-enkephalin) and DPLPE (d-Pen2-l-Pen5-enkephalin) , 1989, Neuropharmacology.

[6]  T. Kameyama,et al.  Blockade of dopamine D1 receptors by SCH 23390 antagonizes discriminative stimulus effects of pentazocine , 1989, Brain Research.

[7]  J. Walker,et al.  Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. , 1988, The Journal of pharmacology and experimental therapeutics.

[8]  P. Portoghese,et al.  Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. , 1988, The Journal of pharmacology and experimental therapeutics.

[9]  T. Kameyama,et al.  Apomorphine markedly potentiates naltrexone-induced hypodipsia in the rat , 1988, Brain Research.

[10]  F. Leslie.  Methods used for the study of opioid receptors. , 1987, Pharmacological reviews.

[11]  K. Polgar,et al.  Modulation by enkephalin analogues and neuroleptics of apomorphine-induced stereotypy and turning behaviour in rats , 1987, Neuropharmacology.

[12]  J. Kamien,et al.  Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys. , 1987, The Journal of pharmacology and experimental therapeutics.

[13]  L. G. Davis,et al.  Neuropeptide modulation of apomorphine-induced stereotyped behavior , 1987, Brain Research.

[14]  K. W. Locke,et al.  Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats. , 1986, The Journal of pharmacology and experimental therapeutics.

[15]  T. Kameyama,et al.  Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist , 1985, Brain Research.

[16]  J. Kamien,et al.  Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline , 1985, Pharmacology Biochemistry and Behavior.

[17]  J. C. Stoof,et al.  Two dopamine receptors: biochemistry, physiology and pharmacology. , 1984, Life sciences.

[18]  A. McKnight,et al.  Selectivities of opioid peptide analogues as agonists and antagonists at the δ‐receptor , 1984 .

[19]  V. Hruby,et al.  Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids. , 1984, The Journal of pharmacology and experimental therapeutics.

[20]  T. Kameyama,et al.  Naloxone reverses the inhibitory effects of dynorphin A on motor activity in the mouse , 1984, Pharmacology Biochemistry and Behavior.

[21]  G. Wardeh,et al.  κ and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release , 1984, Nature.

[22]  T. Kameyama,et al.  Nonopiate effects of α-neo-endorphin on mouse behavior using multi-dimensional behavioral analyses , 1984, Peptides.

[23]  J. Costentin,et al.  Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats. , 1983, European journal of pharmacology.

[24]  T F Burks,et al.  Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Kameyama,et al.  Multi-dimensional analyses of behavior in mice treated with morphine, endorphins and [des-tyrosine1]-γ-endorphin , 1983, Pharmacology Biochemistry and Behavior.

[26]  E. T. Iwamoto.  Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists. , 1981, The Journal of pharmacology and experimental therapeutics.

[27]  D. L. Larson,et al.  A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. , 1980, Journal of medicinal chemistry.

[28]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.